secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001104659-24-090546
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet Biosciences enters into $75M ATM equity sales agreement with Cantor Fitzgerald
--------------------------------------------------------------------------------

- Controlled Equity Offering Sales Agreement with Cantor Fitzgerald dated August 15, 2024.
- Company may sell up to $75M of Series A common stock through at-the-market offerings.
- Agent entitled to commission of up to 3% of gross proceeds from each sale.
- Company has no obligation to sell shares and may suspend or terminate at any time.
- Registration statement on Form S-3 filed same day; sales only after SEC declares effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/0001104659-24-090546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/tm2421627d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-090546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer